VTVT vTv Therapeutics Inc - Ordinary Shares - Class A

$VTVT vTv Therapeutics Announces Oral Presentation at Breakthrough T1D Clinical and Research Congress 2026 "Today announced that Chief Medical Officer Thomas Strack, M.D., Ph.D., presented research spotlighting hypoglycemia-related burdens among adults with T1D using automated insulin delivery (AID) systems at the inaugural Breakthrough T1D Clinical & Research Congress (CRC 2026) in Philadelphia, PA. Cadisegliatin is a potential first-in-class, liver-selective glucokinase activator (GKA) being evaluated as an oral adjunctive therapy to insulin for the treatment of T1D."

$VTVT If HPPD receives FDA approval and meets the relevant conditions, vTv could receive seven years of protection against FDA approval of the same drug for the same indication + development support + tax incentives + reduction of regulatory costs

$VTVT other major investors Samsara BioCapital, L.P 403,942 shares Invus Global Management, LLC 393,098 shares Trails Edge Capital Partners, LP 340,536 shares and Baker Bros. Advisors Lp are IN 148,314 shares

$VTVT "Completing enrollment for the CATT1 study is a significant milestone for vTv, and we're deeply grateful to the study participants whose commitment made this possible," said Paul Sekhri, Chairman, President and Chief Executive Officer of vTv Therapeutics. "Cadisegliatin has the potential to reduce the risk of hypoglycemia, which remains a significant unmet need for people living with T1D, and we look forward to completing the study and reporting topline results in mid 2027."

$VTVT stay in reality land. They will not have data for at least another 8 months. Why buy now??? So many better deals out there

$VTVT add 200 shares, total now 2450 huge and strong support area after a lot of great news long and strong $VTVT ready for reversal next target 44 56. 84 fda next year = 120 240 480$

$VTVT Was 33.00 in the premarket with this orphan drug designation (I guess) what happen?

$VTVT nice update on cadisegliatin. Data in mid 2027. Hopefully this climbs up into data release.

$VTVT despite news so very little volume. At some point the very low volume will switch and the stock will be well below $30. Holding many short shares. If I could I would get many more short shares. Literally nothing bullish yet.

$VTVT How can one believe the person that keeps saying king and strong as the stock falls???

$VTVT revised its bylaws, adopting a third amended and restated version that updates director nomination and voting procedures.